| BPD-BTE-003-02-04 | 400 µg | 1,668.00 USD |  |
||
| BPD-BTE-003-02-1 | 1 mg | 3,791.00 USD | |
||
| Do you need bulk/larger quantities? | |||||
| Alternative Name: | Collagen type II, Procollagen type II N-terminal propeptide, PIIANP |
| Clone: | 2 |
| Host: | Mouse |
| Isotype: | IgG1 |
| Immunogen: | Recombinant PIIANP. |
| UniProt ID: | P02458 |
| GenBank ID: | 1280 |
| Source: | From culture supernatant. |
| Species reactivity: | Human |
| Specificity: | Epitope is located at the amino-terminal part of procollagen type IIA. |
| Applications: | ELISA, IHC (PS) |
| Purity Detail: | Protein A/G-purified. |
| Formulation: | Liquid. In 0.01M phosphate buffer, pH 7.4, containing 0.5M sodium chloride and 15mM sodium azide. |
| Shipping: | Blue Ice Not Frozen |
| Long Term Storage: | +4°C |
| Scientific Background: | Collagen type II is the most abundant protein of cartilage matrix. Two isoforms exist, and collagen type IIA is involved in early development of cartilage in embryos. The collagen is produced from type II procollagen when two teloterminal propeptides are digested from the procursor and released into the circulation. Procollagen type II N-terminal propeptide (PIIANP) is considered a marker of cartilage synthesis, and the normal concentration in serum is approximately 30 ng/mL. |
| Regulatory Status: | RUO - Research Use Only |
